Vindhya Data Science ("Vindhya" or the "Company"), a women-owned leading bioinformatics service provider announced publication of three research reports pertaining to associations between dental/oral ...

Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that it has been named a Houston Top Workplace for 2024 by the Houston Chronicle ...

The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.

Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...

Roche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) ...

Halozyme Therapeutics has bid to buy Evotec for around 2 billion euros ($2.1 billion). Evotec confirmed it received an offer ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Bill Anderson's replacement as chief executive of Roche Pharmaceuticals has been ... which rose by the same margin and a 3% increase for diagnostics to CHF 17.7 billion. Schwan said on the ...

Roche noted in its update that giredestrant is also in additional studies as a first-line therapy for advanced breast cancer and for early-stage breast cancer. Diagnostics drive Q1 performance The ...

catalog albums the week's most popular albums across all genres at least 18 months old and that have fallen below no. 100 on the billboard 200, based on multimetric consumption, blending ...